Revenue in heart health
100%- Transcatheter Aortic Valve Replacement (TAVR) (counted)74%
- Transcatheter Mitral and Tricuspid Therapies (TMTT) (counted)9%
- Surgical Structural Heart (counted)17%
Price against value
No margin of safetyPrice 66% above base case · price Friday 20th November 2026